before couple of years, the UK has witnessed a revolution in healthcare weight‑decline treatment plans — in the introduction of semaglutide (Wegovy®) towards the rising attractiveness of tirzepatide (Mounjaro®). Now, An additional identify is drawing notice in both equally scientific and public h